ZA200806413B - Proteasom or UPS inhibitor for treating infections with influenza viruses - Google Patents

Proteasom or UPS inhibitor for treating infections with influenza viruses

Info

Publication number
ZA200806413B
ZA200806413B ZA200806413A ZA200806413A ZA200806413B ZA 200806413 B ZA200806413 B ZA 200806413B ZA 200806413 A ZA200806413 A ZA 200806413A ZA 200806413 A ZA200806413 A ZA 200806413A ZA 200806413 B ZA200806413 B ZA 200806413B
Authority
ZA
South Africa
Prior art keywords
proteasom
influenza viruses
treating infections
ups inhibitor
ups
Prior art date
Application number
ZA200806413A
Other languages
English (en)
Inventor
Ulrich Schubert
Stephan Ludwig
Oliver Planz
Original Assignee
Virologik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virologik Gmbh filed Critical Virologik Gmbh
Publication of ZA200806413B publication Critical patent/ZA200806413B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200806413A 2006-02-17 2008-07-23 Proteasom or UPS inhibitor for treating infections with influenza viruses ZA200806413B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006008321A DE102006008321A1 (de) 2006-02-17 2006-02-17 Mittel zur Behandlung von Infektionen mit Influenzaviren

Publications (1)

Publication Number Publication Date
ZA200806413B true ZA200806413B (en) 2010-02-24

Family

ID=38110461

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806413A ZA200806413B (en) 2006-02-17 2008-07-23 Proteasom or UPS inhibitor for treating infections with influenza viruses

Country Status (15)

Country Link
US (1) US20090074716A1 (fr)
EP (1) EP1988972A2 (fr)
JP (1) JP2009526824A (fr)
KR (1) KR20080096826A (fr)
CN (1) CN101384301A (fr)
AU (1) AU2007216478A1 (fr)
BR (1) BRPI0708073A2 (fr)
CA (1) CA2642751A1 (fr)
DE (1) DE102006008321A1 (fr)
IL (1) IL193466A0 (fr)
MX (1) MX2008010569A (fr)
NO (1) NO20083916L (fr)
RU (1) RU2008137140A (fr)
WO (1) WO2007093635A2 (fr)
ZA (1) ZA200806413B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011009961A1 (fr) * 2009-07-24 2011-01-27 Virologik Gmbh Association d'inhibiteurs du protéasome et de médicaments anti-hépatite dans le traitement de l'hépatite
CN110093322B (zh) * 2019-05-14 2020-05-15 中国农业科学院兰州兽医研究所 Mg132作为疫苗生产增效剂及稳定剂的应用
CN110812472B (zh) * 2019-11-19 2022-10-21 福建医科大学 E3泛素连接酶stub1在抑制乙型肝炎病毒复制中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1930900A (en) * 1998-12-04 2000-06-26 University Of Maryland Biotechnology Institute Use of protease inhibitors to modulate cellular pathways, immunity and therapiesassociated therewith
WO2003064453A2 (fr) * 2002-01-27 2003-08-07 Viromics Gmbh Inhibiteurs de type 'cheval de troie', procede de production et utilisation desdits inhibiteurs
DE10391147D2 (de) * 2002-04-05 2005-02-17 Viromics Gmbh Mittel zur Behandlung von Flaviviridae-Infektionen
WO2004004749A1 (fr) * 2002-07-03 2004-01-15 Charite - Universitätsmedizin Berlin Inhibiteurs du proteaseome pour le traitement de sujets infectes par un herpes-virus
DE10300222A1 (de) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
DE602004025708D1 (de) * 2003-07-11 2010-04-08 Proteologics Inc Ubiquitin-ligase-hemmer und verwandte verfahren

Also Published As

Publication number Publication date
AU2007216478A1 (en) 2007-08-23
RU2008137140A (ru) 2010-03-27
IL193466A0 (en) 2009-08-03
BRPI0708073A2 (pt) 2011-05-17
CN101384301A (zh) 2009-03-11
MX2008010569A (es) 2008-10-09
CA2642751A1 (fr) 2007-08-23
KR20080096826A (ko) 2008-11-03
DE102006008321A1 (de) 2007-08-30
US20090074716A1 (en) 2009-03-19
NO20083916L (no) 2008-11-14
WO2007093635A3 (fr) 2007-12-13
WO2007093635A2 (fr) 2007-08-23
JP2009526824A (ja) 2009-07-23
EP1988972A2 (fr) 2008-11-12

Similar Documents

Publication Publication Date Title
HRP20160410T8 (hr) Inhibitori hepatitis c virusa
IL198087A0 (en) Methods of inactivating viruses
CR10831A (es) INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
EP2195010A4 (fr) Traitement par des inhibiteurs de la kallikréine
EP2001516A4 (fr) Vaccins pour des virus provoquant des infections persistantes ou latentes
EP2195011A4 (fr) Traitement avec des inhibiteurs de kallikréine
EP2015635A4 (fr) Solutions désinfectantes à amélioration synergique
SI2094702T1 (sl) Virusni inhibitorji
GB0714578D0 (en) Viruses
EP2217573A4 (fr) Traitement et prévention d'infections virales
DE602007013146D1 (de) Plasmaanzeigetafel
ZA201004693B (en) Vortex inhibitor
ZA200806413B (en) Proteasom or UPS inhibitor for treating infections with influenza viruses
FI20095578A (fi) Järjestely substraatin käsittelemiseksi sekä asennusalusta substraattia varten
DE602007001724D1 (de) Plasmaanzeigetafel
DE502006005852D1 (de) Anleger
ZA200903379B (en) Hepatitis C virus inhibitors
NO20060728L (no) Evakueringssystem
TWI316060B (en) Neuraminidase inhibitor
HUS1500008I1 (hu) Hepatitis C vírus inhibitorok
ZA200903014B (en) Hepatitis C virus inhibitors
MA29057B1 (fr) Piece perfectionnee
GB0622190D0 (en) Oncolytic viruses
GB0703066D0 (en) Viruses
FI20075789A0 (fi) Salibandymaila ja otenauha sitä varten